Correlation Between Bristol-Myers Squibb and BM Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and BM Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and BM Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and BM Technologies WT, you can compare the effects of market volatilities on Bristol-Myers Squibb and BM Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of BM Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and BM Technologies.

Diversification Opportunities for Bristol-Myers Squibb and BM Technologies

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bristol-Myers and BMTX-WT is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and BM Technologies WT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BM Technologies WT and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with BM Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BM Technologies WT has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and BM Technologies go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and BM Technologies

Assuming the 90 days horizon Bristol-Myers Squibb is expected to generate 70.6 times less return on investment than BM Technologies. But when comparing it to its historical volatility, Bristol Myers Squibb is 23.42 times less risky than BM Technologies. It trades about 0.04 of its potential returns per unit of risk. BM Technologies WT is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  2.00  in BM Technologies WT on August 27, 2024 and sell it today you would earn a total of  44.00  from holding BM Technologies WT or generate 2200.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy84.62%
ValuesDaily Returns

Bristol Myers Squibb  vs.  BM Technologies WT

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol-Myers Squibb reported solid returns over the last few months and may actually be approaching a breakup point.
BM Technologies WT 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BM Technologies WT are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, BM Technologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

Bristol-Myers Squibb and BM Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol-Myers Squibb and BM Technologies

The main advantage of trading using opposite Bristol-Myers Squibb and BM Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, BM Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BM Technologies will offset losses from the drop in BM Technologies' long position.
The idea behind Bristol Myers Squibb and BM Technologies WT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum